• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

永生细胞的分化会抑制端粒酶活性。

Differentiation of immortal cells inhibits telomerase activity.

作者信息

Sharma H W, Sokoloski J A, Perez J R, Maltese J Y, Sartorelli A C, Stein C A, Nichols G, Khaled Z, Telang N T, Narayanan R

机构信息

Division of Oncology, Roche Research Center, Hoffmann-La Roche Inc., Nutley, NJ 07110, USA.

出版信息

Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12343-6. doi: 10.1073/pnas.92.26.12343.

DOI:10.1073/pnas.92.26.12343
PMID:8618897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC40353/
Abstract

Telomerase, a ribonucleic acid-protein complex, adds hexameric repeats of 5'-TTAGGG-3' to the ends of mammalian chromosomal DNA (telomeres) to compensate for the progressive loss that occurs with successive rounds of DNA replication. Although somatic cells do not express telomerase, germ cells and immortalized cells, including neoplastic cells, express this activity. To determine whether the phenotypic differentiation of immortalized cells is linked to the regulation of telomerase activity, terminal differentiation was induced in leukemic cell lines by diverse agents. A pronounced downregulation of telomerase activity was produced as a consequence of the differentiated status. The differentiation-inducing agents did not directly inhibit telomerase activity, suggesting that the inhibition of telomerase activity is in response to induction of differentiation. The loss of telomerase activity was not due to the production of an inhibitor, since extracts from differentiated cells did not cause inhibition of telomerase activity. By using additional cell lineages including epithelial and embryonal stem cells, down-regulation of telomerase activity was found to be a general response to the induction of differentiation. These findings provide the first direct link between telomerase activity and terminal differentiation and may provide a model to study regulation of telomerase activity.

摘要

端粒酶是一种核糖核酸 - 蛋白质复合物,它将5'-TTAGGG-3'的六聚体重复序列添加到哺乳动物染色体DNA(端粒)的末端,以补偿连续几轮DNA复制过程中发生的渐进性损失。虽然体细胞不表达端粒酶,但生殖细胞和永生化细胞,包括肿瘤细胞,都表达这种活性。为了确定永生化细胞的表型分化是否与端粒酶活性的调节有关,通过多种试剂诱导白血病细胞系发生终末分化。分化状态导致端粒酶活性明显下调。分化诱导剂并未直接抑制端粒酶活性,这表明端粒酶活性的抑制是对分化诱导的反应。端粒酶活性的丧失并非由于产生了抑制剂,因为分化细胞的提取物并未导致端粒酶活性受到抑制。通过使用包括上皮细胞和胚胎干细胞在内的其他细胞谱系,发现端粒酶活性的下调是对分化诱导的普遍反应。这些发现首次提供了端粒酶活性与终末分化之间的直接联系,并可能为研究端粒酶活性的调节提供一个模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab3/40353/31b0a9579d3f/pnas01504-0409-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab3/40353/b5cdca6e18cf/pnas01504-0407-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab3/40353/cc559bc6b4af/pnas01504-0408-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab3/40353/0d5cbeebe5ae/pnas01504-0408-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab3/40353/31b0a9579d3f/pnas01504-0409-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab3/40353/b5cdca6e18cf/pnas01504-0407-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab3/40353/cc559bc6b4af/pnas01504-0408-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab3/40353/0d5cbeebe5ae/pnas01504-0408-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab3/40353/31b0a9579d3f/pnas01504-0409-a.jpg

相似文献

1
Differentiation of immortal cells inhibits telomerase activity.永生细胞的分化会抑制端粒酶活性。
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12343-6. doi: 10.1073/pnas.92.26.12343.
2
Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines.在永生细胞系终末分化过程中端粒酶活性的选择性抑制。
Cancer Res. 1996 Aug 15;56(16):3796-802.
3
Telomere reduction and telomerase inactivation during neuronal cell differentiation.
Biochem Biophys Res Commun. 1996 Jul 16;224(2):487-92. doi: 10.1006/bbrc.1996.1054.
4
Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein.分化剂使HL60细胞中的端粒酶活性下调,同时端粒酶相关蛋白的表达增加。
J Cell Biochem. 1997 Oct 1;67(1):13-23.
5
Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.不同维甲酸耐药性早幼粒细胞白血病细胞的常见缺陷是端粒酶活性持续存在和核体紊乱。
Differentiation. 1997 Aug;61(5):321-31. doi: 10.1046/j.1432-0436.1997.6150321.x.
6
Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change.端粒酶活性下调是细胞分化的早期事件,且无明显的端粒DNA变化。
Leuk Res. 1998 Aug;22(8):711-7. doi: 10.1016/s0145-2126(98)00065-4.
7
Differences in expression of transcription factor AP-1 in human promyelocytic HL-60 cells during differentiation towards macrophages versus granulocytes.人早幼粒细胞HL-60细胞在向巨噬细胞和粒细胞分化过程中转录因子AP-1表达的差异。
Biochem J. 1993 Aug 15;294 ( Pt 1)(Pt 1):137-44. doi: 10.1042/bj2940137.
8
The effect of glutathione on HL-60 treated with dimethylsulfoxide, butyric acid or 12-O-tetradecanoylphorbol-13-acetate.谷胱甘肽对用二甲基亚砜、丁酸或12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯处理的HL - 60细胞的影响。
FEBS Lett. 1983 May 2;155(1):107-12. doi: 10.1016/0014-5793(83)80219-1.
9
Loss and reappearance of transferrin receptors in human leukemic cell lines.
Exp Cell Biol. 1986;54(2):80-8. doi: 10.1159/000163347.
10
Induction of differentiation of mouse myeloid leukemia M1 cells by serum of patients with chronic myeloid leukemia.慢性髓性白血病患者血清诱导小鼠髓性白血病M1细胞分化
Jpn J Cancer Res. 1988 Dec;79(12):1318-26. doi: 10.1111/j.1349-7006.1988.tb01562.x.

引用本文的文献

1
Natural Bioactive Agents: Testable Stem Cell-Targeting Alternatives for Therapy-Resistant Breast Cancer.天然生物活性因子:针对难治性乳腺癌的可测试的干细胞靶向替代疗法
Int J Mol Sci. 2025 Mar 12;26(6):2529. doi: 10.3390/ijms26062529.
2
TERT Promoter Methylation Is Oxygen-Sensitive and Regulates Telomerase Activity.端粒酶逆转录酶启动子甲基化对氧敏感并调节端粒酶活性。
Biomolecules. 2024 Jan 19;14(1):131. doi: 10.3390/biom14010131.
3
Stem Cell Models for Breast and Colon Cancer: Experimental Approach for Drug Discovery.用于乳腺癌和结肠癌的干细胞模型:药物发现的实验方法。

本文引用的文献

1
Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model.利用细胞黏附模型对核因子κB的p50和p65亚基的不同功能的研究证据。
Mol Cell Biol. 1993 Jun;13(6):3802-10. doi: 10.1128/mcb.13.6.3802-3810.1993.
2
Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.核因子-κB p65亚基的反义抑制可阻断肿瘤发生并导致肿瘤消退。
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9901-5. doi: 10.1073/pnas.90.21.9901.
3
Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes.
Int J Mol Sci. 2022 Aug 17;23(16):9223. doi: 10.3390/ijms23169223.
4
Potential of Naturally Derived Compounds in Telomerase and Telomere Modulation in Skin Senescence and Aging.天然化合物在皮肤衰老和老化中端粒酶和端粒调节中的潜力。
Int J Mol Sci. 2021 Jun 15;22(12):6381. doi: 10.3390/ijms22126381.
5
miR-615 Fine-Tunes Growth and Development and Has a Role in Cancer and in Neural Repair.miR-615 精细调节生长发育,在癌症和神经修复中发挥作用。
Cells. 2020 Jun 27;9(7):1566. doi: 10.3390/cells9071566.
6
is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts.是 GATA1 的转录靶标,并驱动正常人类红细胞中端粒酶活性的上调。
Haematologica. 2020 Jun;105(6):1517-1526. doi: 10.3324/haematol.2018.215699. Epub 2019 Aug 14.
7
Evaluation of chemotherapeutic and cancer-protective properties of sphingosine and C2-ceramide in a human breast stem cell derived carcinogenesis model.评估神经酰胺和 C2-神经酰胺在人乳腺干细胞源性致癌模型中的化疗和抗癌特性。
Int J Oncol. 2019 Feb;54(2):655-664. doi: 10.3892/ijo.2018.4641. Epub 2018 Nov 22.
8
Inhibition of cell growth by cellular differentiation into adipocyte-like cells in dexamethasone sensitive cancer cell lines.在地塞米松敏感的癌细胞系中,细胞分化为脂肪细胞样细胞对细胞生长的抑制作用。
Anim Cells Syst (Seoul). 2018 Jun 18;22(3):178-188. doi: 10.1080/19768354.2018.1476408. eCollection 2018.
9
Modulation of Telomerase Activity in Cancer Cells by Dietary Compounds: A Review.膳食化合物对癌细胞端粒酶活性的调控:综述。
Int J Mol Sci. 2018 Feb 6;19(2):478. doi: 10.3390/ijms19020478.
10
HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis.HoxC5 和 miR-615-3p 靶向新进化的基因组区域,抑制 hTERT 并抑制肿瘤发生。
Nat Commun. 2018 Jan 8;9(1):100. doi: 10.1038/s41467-017-02601-1.
针对核因子-κB p65亚基的反义寡核苷酸可阻断CD11b表达并改变分化型HL-60粒细胞的黏附特性。
Blood. 1993 Jul 15;82(2):625-32.
4
Telomerase activity in germline and embryonic cells of Xenopus.非洲爪蟾生殖细胞和胚胎细胞中的端粒酶活性
EMBO J. 1994 Jul 1;13(13):3211-7. doi: 10.1002/j.1460-2075.1994.tb06620.x.
5
Telomere dynamics in an immortal human cell line.
EMBO J. 1994 Oct 17;13(20):4953-62. doi: 10.1002/j.1460-2075.1994.tb06822.x.
6
Telomeres, cancer, and immortality.
N Engl J Med. 1995 Apr 6;332(14):955-6. doi: 10.1056/NEJM199504063321412.
7
Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas.人类肝脏组织中的端粒酶活性:慢性肝病与肝细胞癌的比较
Cancer Res. 1995 Jul 1;55(13):2734-6.
8
Telomerase activity in normal leukocytes and in hematologic malignancies.正常白细胞和血液系统恶性肿瘤中的端粒酶活性。
Blood. 1995 May 1;85(9):2315-20.
9
Is telomerase a universal cancer target?端粒酶是一种通用的癌症靶点吗?
J Natl Cancer Inst. 1995 Jun 21;87(12):859-61. doi: 10.1093/jnci/87.12.859.
10
Specific association of human telomerase activity with immortal cells and cancer.人类端粒酶活性与永生化细胞及癌症的特定关联。
Science. 1994 Dec 23;266(5193):2011-5. doi: 10.1126/science.7605428.